These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. Cakebread JA; Xu Y; Grainge C; Kehagia V; Howarth PH; Holgate ST; Davies DE J Allergy Clin Immunol; 2011 May; 127(5):1148-54.e9. PubMed ID: 21329968 [TBL] [Abstract][Full Text] [Related]
9. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Baines KJ; Hsu AC; Tooze M; Gunawardhana LP; Gibson PG; Wark PA Respir Res; 2013 Feb; 14(1):15. PubMed ID: 23384071 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results. Petrova NV; Emelyanova AG; Gorbunov EA; Edwards MR; Walton RP; Bartlett NW; Aniscenko J; Gogsadze L; Bakhsoliani E; Khaitov MR; Johnston SL; Tarasov SA; Epstein OI Antiviral Res; 2017 Jun; 142():185-192. PubMed ID: 28356234 [TBL] [Abstract][Full Text] [Related]
11. Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma. Krammer S; Sicorschi Gutu C; Grund JC; Chiriac MT; Zirlik S; Finotto S Front Immunol; 2021; 12():731807. PubMed ID: 34899691 [TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13). Hansel TT; Tunstall T; Trujillo-Torralbo MB; Shamji B; Del-Rosario A; Dhariwal J; Kirk PDW; Stumpf MPH; Koopmann J; Telcian A; Aniscenko J; Gogsadze L; Bakhsoliani E; Stanciu L; Bartlett N; Edwards M; Walton R; Mallia P; Hunt TM; Hunt TL; Hunt DG; Westwick J; Edwards M; Kon OM; Jackson DJ; Johnston SL EBioMedicine; 2017 May; 19():128-138. PubMed ID: 28373098 [TBL] [Abstract][Full Text] [Related]
14. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737 [TBL] [Abstract][Full Text] [Related]
16. IL-33 Induces an Antiviral Signature in Mast Cells but Enhances Their Permissiveness for Human Rhinovirus Infection. Akoto C; Willis A; Banas CF; Bell JA; Bryant D; Blume C; Davies DE; Swindle EJ Viruses; 2022 Nov; 14(11):. PubMed ID: 36366528 [TBL] [Abstract][Full Text] [Related]
17. In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection. Farne H; Lin L; Jackson DJ; Rattray M; Simpson A; Custovic A; Joshi S; Wilson PA; Williamson R; Edwards MR; Singanayagam A; Johnston SL Thorax; 2022 Sep; 77(9):929-932. PubMed ID: 35790388 [TBL] [Abstract][Full Text] [Related]
18. Poly I:C Pre-Treatment Induced the Anti-Viral Interferon Response in Airway Epithelial Cells. Mitländer H; Yang Z; Krammer S; Grund JC; Zirlik S; Finotto S Viruses; 2023 Nov; 15(12):. PubMed ID: 38140569 [TBL] [Abstract][Full Text] [Related]